Rheumatology (Oxford, England)
The impact of glucocorticoids on the efficacy of JAK inhibitors or non-TNF-targeted biologics in rheumatoid arthritis.
Mariangela Salvato, Benedetta Salvatori, Francesca Frizzera, Federico Arru, Kiren Khalid, Lorenzo Di Luozzo, Margherita Zen, Andrea Doria, Alessandro Giollo
Published: 202510.1093/rheumatology/keaf612
Abstract
OBJECTIVES: To evaluate the impact of oral low-dose glucocorticoids (GC) on the effectiveness of Janus kinase inhibitors (JAKi) compared with non-TNF-targeted bDMARDs (other mechanisms of action [OMA] including tocilizumab, abatacept, and rituximab),…
Preview only. Read the full abstract at the source